Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Accumulated Depreciation (2020 - 2025)

Historic Accumulated Depreciation for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $4.3 million.

  • Pulse Biosciences' Accumulated Depreciation rose 1067.74% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 1067.74%. This contributed to the annual value of $4.0 million for FY2024, which is 1415.42% up from last year.
  • Per Pulse Biosciences' latest filing, its Accumulated Depreciation stood at $4.3 million for Q3 2025, which was up 1067.74% from $4.2 million recorded in Q2 2025.
  • Over the past 5 years, Pulse Biosciences' Accumulated Depreciation peaked at $4.3 million during Q3 2025, and registered a low of $2.0 million during Q1 2021.
  • For the 5-year period, Pulse Biosciences' Accumulated Depreciation averaged around $3.2 million, with its median value being $3.2 million (2023).
  • Per our database at Business Quant, Pulse Biosciences' Accumulated Depreciation skyrocketed by 2874.17% in 2022 and then skyrocketed by 1067.74% in 2025.
  • Quarter analysis of 5 years shows Pulse Biosciences' Accumulated Depreciation stood at $2.4 million in 2021, then rose by 23.25% to $3.0 million in 2022, then rose by 17.71% to $3.5 million in 2023, then grew by 14.15% to $4.0 million in 2024, then increased by 7.89% to $4.3 million in 2025.
  • Its last three reported values are $4.3 million in Q3 2025, $4.2 million for Q2 2025, and $4.1 million during Q1 2025.